col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


83 Results       Page 1

 [1] 
Springer Science and Business Media LLC: Cell Research
  original article Date Title Authors   All Authors
1 [GO] 2022―Nov―10 A variant-proof SARS-CoV-2 vaccine targeting HR1 domain in S2 subunit of spike protein Wei Pang, Ying Lu, Yan-Bo Zhao, Fan Shen, Chang-Fa Fan, Qian Wang, et al. (+20)
2 [GO] 2022―Sep―27 Deep learning-based rapid generation of broadly reactive antibodies against SARS-CoV-2 and its Omicron variant Hantao Lou, Jianqing Zheng, Xiaohang Fang, Zhu Liang, Meihan Zhang, Yu Chen, et al. (+2)
3 [GO] 2022―Sep―21 Proviral role of caspase-6 in coronavirus infections Lok-Yin Roy Wong, Stanley Perlman
4 [GO] 2022―Sep―14 mRNA vaccines expressing homo-prototype/Omicron and hetero-chimeric RBD-dimers against SARS-CoV-2 Yuxuan Han, Yaling An, Qian Chen, Kun Xu, Xueyuan Liu, Senyu Xu, et al. (+6)
5 [GO] 2022―Sep―01 Publisher Correction: Dalbavancin: novel candidate for COVID-19 treatment Markus Hoffmann, Yeonhwa Jin, Stefan Pöhlmann
6 [GO] 2022―Jul―29 Hetero-bivalent nanobodies provide broad-spectrum protection against SARS-CoV-2 variants of concern including Omicron Huan Ma, Xinghai Zhang, Peiyi Zheng, Peter H. Dube, Weihong Zeng, Shaohong Chen, et al. (+9)
7 [GO] 2022―Jun―29 A broadly neutralizing antibody against SARS-CoV-2 Omicron variant infection exhibiting a novel trimer dimer conformation in spike protein binding Yingdan Wang, Wuqiang Zhan, Jiangyan Liu, Yanqun Wang, Xiang Zhang, Meng Zhang, et al. (+9)
8 [GO] 2022―Jun―14 Safety and superior immunogenicity of heterologous boosting with an RBD-based SARS-CoV-2 mRNA vaccine in Chinese adults Xiaoqiang Liu, Yuhua Li, Zhongfang Wang, Shouchun Cao, Weijin Huang, Lin Yuan, et al. (+9)
9 [GO] 2022―Jun―07 Selection and structural bases of potent broadly neutralizing antibodies from 3-dose vaccinees that are highly effective against diverse SARS-CoV-2 variants, including Omicron sublineages Lei Wang, Wangjun Fu, Linlin Bao, Zijing Jia, Yuxia Zhang, Yunjiao Zhou, et al. (+8)
10 [GO] 2022―Apr―13 Enhanced trimeric ACE2 exhibits potent prophylactic and therapeutic efficacy against the SARS-CoV-2 Delta and Omicron variants in vivo Mengjiao Li, Zi-Wei Ye, Kaiming Tang, Liang Guo, Wenwen Bi, Yuyuan Zhang, et al. (+7)
11 [GO] 2022―Apr―13 Structural insights into the SARS-CoV-2 Omicron RBD-ACE2 interaction Jun Lan, Xinheng He, Yifei Ren, Ziyi Wang, Huan Zhou, Shilong Fan, et al. (+9)
12 [GO] 2022―Apr―01 Author Correction: Receptome profiling identifies KREMEN1 and ASGR1 as alternative functional receptors of SARS-CoV-2 Yunqing Gu, Jun Cao, Xinyu Zhang, Hai Gao, Yuyan Wang, Jia Wang, et al. (+20)
13 [GO] 2022―Mar―21 Lipid nanoparticle-mRNA: another step in the fight against COVID-19 Abhishek Kumar Verma, Stanley Perlman
14 [GO] 2022―Mar―15 The P132H mutation in the main protease of Omicron SARS-CoV-2 decreases thermal stability without compromising catalysis or small-molecule drug inhibition Michael Dominic Sacco, Yanmei Hu, Maura Verenice Gongora, Flora Meilleur, Michael Trent Kemp, Xiujun Zhang, et al. (+2)
15 [GO] 2022―Mar―08 Immune escape by SARS-CoV-2 Omicron variant and structural basis of its effective neutralization by a broad neutralizing human antibody VacW-209 Bin Ju, Qingbing Zheng, Huimin Guo, Qing Fan, Tingting Li, Shuo Song, et al. (+9)
16 [GO] 2022―Mar―08 Innovative adjuvant augments potency of a SARS-CoV-2 subunit vaccine Hua Peng, Yang-Xin Fu
17 [GO] 2022―Feb―24 Lipid nanoparticle-encapsulated mRNA antibody provides long-term protection against SARS-CoV-2 in mice and hamsters Yong-Qiang Deng, Na-Na Zhang, Yi-Fei Zhang, Xia Zhong, Sue Xu, Hong-Ying Qiu, et al. (+15)
18 [GO] 2022―Feb―24 A pan-sarbecovirus vaccine induces highly potent and durable neutralizing antibody responses in non-human primates against SARS-CoV-2 Omicron variant Zezhong Liu, Jasper Fuk-Woo Chan, Jie Zhou, Meiyu Wang, Qian Wang, Guangxu Zhang, et al. (+7)
19 [GO] 2022―Feb―14 Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant Na-Na Zhang, Rong-Rong Zhang, Yi-Fei Zhang, Kai Ji, Xiao-Chuan Xiong, Qian-Shan Qin, et al. (+6)
20 [GO] 2022―Jan―27 Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant Shuai Xia, Jasper Fuk-Woo Chan, Lijue Wang, Fanke Jiao, Kenn Ka-Heng Chik, Hin Chu, et al. (+7)
21 [GO] 2022―Jan―21 Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant of SARS-CoV-2 isolates Denisa Bojkova, Marek Widera, Sandra Ciesek, Mark N. Wass, Martin Michaelis, Jindrich Cinatl
22 [GO] 2022―Jan―20 SARS-CoV-2 Omicron variant is highly sensitive to molnupiravir, nirmatrelvir, and the combination Pengfei Li, Yining Wang, Marla Lavrijsen, Mart M. Lamers, Annemarie C. de Vries, Robbert J. Rottier, et al. (+4)
23 [GO] 2022―Jan―12 Loss of Spike N370 glycosylation as an important evolutionary event for the enhanced infectivity of SARS-CoV-2 Shuyuan Zhang, Qingtai Liang, Xinheng He, Chongchong Zhao, Wenlin Ren, Ziqing Yang, et al. (+6)
24 [GO] 2021―Dec―13 Novel SARS-CoV-2 receptors: ASGR1 and KREMEN1 Markus Hoffmann, Stefan Pöhlmann
25 [GO] 2021―Nov―26 Receptome profiling identifies KREMEN1 and ASGR1 as alternative functional receptors of SARS-CoV-2 Yunqing Gu, Jun Cao, Xinyu Zhang, Hai Gao, Yuyan Wang, Jia Wang, et al. (+20)
26 [GO] 2021―Nov―23 Recombinant protein subunit vaccine booster following two-dose inactivated vaccines dramatically enhanced anti-RBD responses and neutralizing titers against SARS-CoV-2 and Variants of Concern Jingwen Ai, Haocheng Zhang, Qiran Zhang, Yi Zhang, Ke Lin, Zhangfan Fu, et al. (+7)
27 [GO] 2021―Nov―04 Comparison of viral RNA-host protein interactomes across pathogenic RNA viruses informs rapid antiviral drug discovery for SARS-CoV-2 Shaojun Zhang, Wenze Huang, Lili Ren, Xiaohui Ju, Mingli Gong, Jian Rao, et al. (+5)
28 [GO] 2021―Oct―26 Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms Rongjia Zhu, Tingdong Yan, Yingmei Feng, Yan Liu, Hongcui Cao, Gongxin Peng, et al. (+46)
29 [GO] 2021―Oct―18 SARS-CoV-2 promotes RIPK1 activation to facilitate viral propagation Gang Xu, Ying Li, Shengyuan Zhang, Haoran Peng, Yunyun Wang, Dekang Li, et al. (+15)
30 [GO] 2021―Oct―12 Distinct immune signatures discriminate between asymptomatic and presymptomatic SARS-CoV-2pos subjects Shanhe Yu, Caixia Di, Shijun Chen, Mingquan Guo, Jiayang Yan, Zhaoqin Zhu, et al. (+14)
31 [GO] 2021―Sep―29 Author Correction: Mechanical activation of spike fosters SARS-CoV-2 infection Wei Hu, Yong Zhang, Panyu Fei, Tongtong Zhang, Danmei Yao, Yufei Gao, et al. (+15)
32 [GO] 2021―Sep―29 Tracing the origins of SARS-CoV-2: lessons learned from the past Qihui Wang, Hua Chen, Yi Shi, Alice C. Hughes, William J. Liu, Jingkun Jiang, et al. (+3)
33 [GO] 2021―Sep―28 Design and development of an oral remdesivir derivative VV116 against SARS-CoV-2 Yuanchao Xie, Wanchao Yin, Yumin Zhang, Weijuan Shang, Zhen Wang, Xiaodong Luan, et al. (+10)
34 [GO] 2021―Sep―20 Author Correction: Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2 Shiyu Sun, Yueqi Cai, Tian-Zhang Song, Yang Pu, Lin Cheng, Hairong Xu, et al. (+20)
35 [GO] 2021―Sep―03 Structure-based analyses of neutralization antibodies interacting with naturally occurring SARS-CoV-2 RBD variants Hua Xu, Bo Wang, Tian-Ning Zhao, Zi-Teng Liang, Tian-Bo Peng, Xiao-Hui Song, et al. (+3)
36 [GO] 2021―Sep―01 Timing vaccination against SARS-CoV-2 Coline Barnoud, Chen Wang, Christoph Scheiermann
37 [GO] 2021―Aug―31 Mechanical activation of spike fosters SARS-CoV-2 viral infection Wei Hu, Yong Zhang, Panyu Fei, Tongtong Zhang, Danmei Yao, Yufei Gao, et al. (+15)
38 [GO] 2021―Aug―25 Structures of SARS-CoV-2 B.1.351 neutralizing antibodies provide insights into cocktail design against concerning variants Shuo Du, Pulan Liu, Zhiying Zhang, Tianhe Xiao, Ayijiang Yasimayi, Weijin Huang, et al. (+4)
39 [GO] 2021―Aug―02 Time of day influences immune response to an inactivated vaccine against SARS-CoV-2 Hui Zhang, Yihao Liu, Dayue Liu, Qin Zeng, Liubing Li, Qian Zhou, et al. (+8)
40 [GO] 2021―Aug―02 O-glycosylation pattern of the SARS-CoV-2 spike protein reveals an “O-Follow-N” rule Wenmin Tian, Delin Li, Nan Zhang, Guijie Bai, Kai Yuan, Haixia Xiao, et al. (+4)
41 [GO] 2021―Jul―15 Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2 Shiyu Sun, Yueqi Cai, Tian-Zhang Song, Yang Pu, Lin Cheng, Hairong Xu, et al. (+20)
42 [GO] 2021―Jun―16 A cohort autopsy study defines COVID-19 systemic pathogenesis Xiao-Hong Yao, Tao Luo, Yu Shi, Zhi-Cheng He, Rui Tang, Pei-Pei Zhang, et al. (+31)
43 [GO] 2021―Jun―10 SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target Bingqing Xia, Xurui Shen, Yang He, Xiaoyan Pan, Feng-Liang Liu, Yi Wang, et al. (+28)
44 [GO] 2021―May―21 Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines Yunlong Cao, Ayijiang Yisimayi, Yali Bai, Weijin Huang, Xiaofeng Li, Zhiying Zhang, et al. (+31)
45 [GO] 2021―May―18 SARS-CoV-2 vaccines: anamnestic response in previously infected recipients Jyothi N. Purushotham, Neeltje van Doremalen, Vincent J. Munster
46 [GO] 2021―Apr―27 Publisher Correction: SARS-CoV-2 spike protein interacts with and activates TLR4 Yingchi Zhao, Ming Kuang, Junhong Li, Ling Zhu, Zijing Jia, Xuefei Guo, et al. (+5)
47 [GO] 2021―Apr―23 The basis of a more contagious 501Y.V1 variant of SARS-CoV-2 Haolin Liu, Qianqian Zhang, Pengcheng Wei, Zhongzhou Chen, Katja Aviszus, John Yang, et al. (+9)
48 [GO] 2021―Mar―29 Structure-based development of three- and four-antibody cocktails against SARS-CoV-2 via multiple mechanisms Yao Sun, Lei Wang, Rui Feng, Nan Wang, Yuxi Wang, Dandan Zhu, et al. (+5)
49 [GO] 2021―Mar―23 Double insult: flu bug enhances SARS-CoV-2 infectivity Shan Su, Zezhong Liu, Shibo Jiang
50 [GO] 2021―Mar―19 SARS-CoV-2 spike protein interacts with and activates TLR41 Yingchi Zhao, Ming Kuang, Junhong Li, Ling Zhu, Zijing Jia, Xuefei Guo, et al. (+5)
51 [GO] 2021―Mar―18 Structural basis for the different states of the spike protein of SARS-CoV-2 in complex with ACE2 Renhong Yan, Yuanyuan Zhang, Yaning Li, Fangfei Ye, Yingying Guo, Lu Xia, et al. (+3)
52 [GO] 2021―Mar―17 Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies Renhong Yan, Ruoke Wang, Bin Ju, Jinfang Yu, Yuanyuan Zhang, Nan Liu, et al. (+19)
53 [GO] 2021―Feb―20 Coinfection with influenza A virus enhances SARS-CoV-2 infectivity Lei Bai, Yongliang Zhao, Jiazhen Dong, Simeng Liang, Ming Guo, Xinjin Liu, et al. (+22)
54 [GO] 2021―Jan―28 The m6A methylome of SARS-CoV-2 in host cells Jun’e Liu, Yan-Peng Xu, Kai Li, Qing Ye, Hang-Yu Zhou, Hanxiao Sun, et al. (+11)
55 [GO] 2021―Jan―21 Discriminating mild from critical COVID-19 by innate and adaptive immune single-cell profiling of bronchoalveolar lavages Els Wauters, Pierre Van Mol, Abhishek Dinkarnath Garg, Sander Jansen, Yannick Van Herck, Lore Vanderbeke, et al. (+22)
56 [GO] 2021―Jan―20 Dalbavancin: novel candidate for COVID-19 treatment Markus Hoffmann, Yeonhwa Jin, Stefan Pöhlmann
57 [GO] 2021―Jan―08 AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells Shuai Wang, Zongyang Qiu, Yingnan Hou, Xiya Deng, Wei Xu, Tingting Zheng, et al. (+14)
58 [GO] 2020―Dec―01 Structure-based development of human antibody cocktails against SARS-CoV-2 Nan Wang, Yao Sun, Rui Feng, Yuxi Wang, Yan Guo, Li Zhang, et al. (+9)
59 [GO] 2020―Dec―01 Dalbavancin binds ACE2 to block its interaction with SARS-CoV-2 spike protein and is effective in inhibiting SARS-CoV-2 infection in animal models Gan Wang, Meng-Li Yang, Zi-Lei Duan, Feng-Liang Liu, Lin Jin, Cheng-Bo Long, et al. (+12)
60 [GO] 2020―Dec―01 SARS-CoV-2-induced lung pathology: AHR as a candidate therapeutic target Federico Giovannoni, Francisco J. Quintana
61 [GO] 2020―Nov―11 Engineered trimeric ACE2 binds viral spike protein and locks it in “Three-up” conformation to potently inhibit SARS-CoV-2 infection Liang Guo, Wenwen Bi, Xinling Wang, Wei Xu, Renhong Yan, Yuanyuan Zhang, et al. (+9)
62 [GO] 2020―Nov―06 Mucus production stimulated by IFN-AhR signaling triggers hypoxia of COVID-19 Yuying Liu, Jiadi Lv, Jiangning Liu, Man Li, Jing Xie, Qi Lv, et al. (+8)
63 [GO] 2020―Nov―02 The SARS-CoV-2 spike protein: balancing stability and infectivity Imre Berger, Christiane Schaffitzel
64 [GO] 2020―Sep―30 Effective treatment of SARS-CoV-2-infected rhesus macaques by attenuating inflammation Shuaiyao Lu, Jingjing Zhao, Jiebin Dong, Hongqi Liu, Yinhua Zhu, Honggang Li, et al. (+9)
65 [GO] 2020―Sep―10 Liquid-liquid phase separation by SARS-CoV-2 nucleocapsid protein and RNA Hui Chen, Yang Cui, Xuling Han, Wei Hu, Min Sun, Yong Zhang, et al. (+4)
66 [GO] 2020―Aug―25 A mouse model for SARS-CoV-2 infection by exogenous delivery of hACE2 using alphavirus replicon particles Ya-Nan Zhang, Xiao-Dan Li, Zhe-Rui Zhang, Hong-Qing Zhang, Na Li, Jing Liu, et al. (+9)
67 [GO] 2020―Aug―18 25-Hydroxycholesterol is a potent SARS-CoV-2 inhibitor Shulong Zu, Yong-Qiang Deng, Chao Zhou, Jie Li, Lili Li, Qi Chen, et al. (+9)
68 [GO] 2020―Aug―17 A COVID-19 mRNA vaccine encoding SARS-CoV-2 virus-like particles induces a strong antiviral-like immune response in mice Jing Lu, Guoliang Lu, Shudan Tan, Jia Xia, Hualong Xiong, Xiaofei Yu, et al. (+8)
69 [GO] 2020―Aug―05 Dysregulated adaptive immune response contributes to severe COVID-19 Kuai Yu, Jingjing He, Yongjian Wu, Baosong Xie, Xuefei Liu, Bo Wei, et al. (+9)
70 [GO] 2020―Aug―05 A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2 Wanbo Tai, Xiujuan Zhang, Aleksandra Drelich, Juan Shi, Jason C. Hsu, Larry Luchsinger, et al. (+4)
71 [GO] 2020―Aug―04 SARS-CoV-2 infects human neural progenitor cells and brain organoids Bao-Zhong Zhang, Hin Chu, Shuo Han, Huiping Shuai, Jian Deng, Ye-fan Hu, et al. (+9)
72 [GO] 2020―Jul―20 Serosurvey of SARS-CoV-2 among hospital visitors in China Wenhua Liang, Yongping Lin, Jianping Bi, Jianfu Li, Ying Liang, Sook-San Wong, et al. (+9)
73 [GO] 2020―Jul―07 Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in Rhesus macaques Chao Shan, Yan-Feng Yao, Xing-Lou Yang, Yi-Wu Zhou, Ge Gao, Yun Peng, et al. (+20)
74 [GO] 2020―Jul―06 Pulmonary alveolar regeneration in adult COVID-19 patients Jingyu Chen, Huijuan Wu, Yuanyuan Yu, Nan Tang
75 [GO] 2020―Jul―01 Mining of epitopes on spike protein of SARS-CoV-2 from COVID-19 patients Bao-zhong Zhang, Ye-fan Hu, Lin-lei Chen, Thomas Yau, Yi-gang Tong, Jing-chu Hu, et al. (+9)
76 [GO] 2020―Jun―30 Distinct stem/progenitor cells proliferate to regenerate the trachea, intrapulmonary airways and alveoli in COVID-19 patients Yinshan Fang, Helu Liu, Huachao Huang, Haiyan Li, Anjali Saqi, Li Qiang, Jianwen Que
77 [GO] 2020―Jun―15 Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease Chunlong Ma, Michael Dominic Sacco, Brett Hurst, Julia Alma Townsend, Yanmei Hu, Tommy Szeto, et al. (+5)
78 [GO] 2020―Apr―29 COVID-19: treating and managing severe cases Jingwen Ai, Yang Li, Xian Zhou, Wenhong Zhang
79 [GO] 2020―Apr―28 COVID-19: towards understanding of pathogenesis Wei Cao, Taisheng Li
80 [GO] 2020―Apr―28 Pathological evidence for residual SARS-CoV-2 in pulmonary tissues of a ready-for-discharge patient Xiao-Hong Yao, Zhi-Cheng He, Ting-Yuan Li, Hua-Rong Zhang, Yan Wang, Huaming Mou, et al. (+6)
81 [GO] 2020―Mar―30 Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion Shuai Xia, Meiqin Liu, Chao Wang, Wei Xu, Qiaoshuai Lan, Siliang Feng, et al. (+10)
82 [GO] 2020―Feb―18 Virus against virus: a potential treatment for 2019-nCov (SARS-CoV-2) and other RNA viruses Tuan M. Nguyen, Yang Zhang, Pier Paolo Pandolfi
83 [GO] 2020―Feb―04 Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro Manli Wang, Ruiyuan Cao, Leike Zhang, Xinglou Yang, Jia Liu, Mingyue Xu, et al. (+4)
 [1] 

83 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.007 sec